From the Food and Drug Administration.
Nightingale
S L
SL
D003024:Clozapine / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D014364:Tryptophan / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D003984:Dibenzazepines; D014364:Tryptophan; D003024:Clozapine; D008691:Methadone